Abcellera Biologics

-$0.16 (-1.96%) As of 1:40 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABCL and other ETFs, options, and stocks.

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.

CEO

Carl Lars G. Hansen

Employees

—

Headquarters

Vancouver, British Columbia

Founded

2012

ABCL Key Statistics

Market cap

Price-Earnings ratio

14.03

Dividend yield

—

Average volume

3.20M

High today

$8.08

Low today

$7.90

Open price

$7.92

Volume

75.69K

52 Week high

$34.00

52 Week low

$5.42

ABCL News

Simply Wall St3h

Insider Buying: The AbCellera Biologics Inc. CEO, President & Chairperson Just Bought 2.6% More Shares - Simply Wall St

AbCellera Biologics Inc. ( ) shareholders (or potential shareholders) will be happy to see that the CEO, President & Chairperson, Carl Hansen, recently bought a

Analyst ratings

Buy

100%

Hold

Sell

ABCL Earnings

-$0.08

$0.15

$0.38

$0.61

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Estimated

$0.33 per share

Actual

$0.54 per share

Replay Earnings Call

Why Robinhood?

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. View more

Insider Buying: The AbCellera Biologics Inc. CEO, President & Chairperson Just Bought 2.6% More Shares - Simply Wall St

100%

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease.